Aperture Therapeutics is focused on developing therapies for neurodegenerative diseases by leveraging genetic insights and machine learning to create oligonucleotide therapeutics that mimic protective gene variants
Aperture Therapeutics is focused on developing therapies for neurodegenerative diseases by leveraging genetic insights and machine learning to create oligonucleotide therapeutics that mimic protective gene variants.
Aperture Therapeutics is focused on developing therapies for neurodegenerative diseases by leveraging genetic insights and machine learning to create oligonucleotide therapeutics that mimic protective gene variants
Aperture Therapeutics is focused on developing therapies for neurodegenerative diseases by leveraging genetic insights and machine learning to create oligonucleotide therapeutics that mimic protective gene variants.